IADR Abstract Archives

In-Vitro Evaluation of Oral Irritation Potential of Three Whitening Dentifrices

Objective: Determine the oral irritation potential of three commercially-available whitening dentifrices with varying surfactant systems using a reconstructed oral tissue model (EpiOral™ - MatTek Corporation).

Method: Products: Products: Surfactant-free dentifrice (REMBRANDT® GENTLE WHITE), pyrophosphate and cocamidopropyl betaine-containing dentifrice (REMBRANDT® INTENSE STAIN®) and pyrophosphate and sodium lauryl sulfate-containing dentifrice (Crest® 3D White). Each product was exposed to duplicate tissues at four different exposure times. The tissue viability was determined by the enzymatic reduction of MTT (3[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide). The toxicity of each product was evaluated on the basis of the relative tissue viability versus exposure time. The duration of exposure resulting in a 50% decrease in MTT conversion in the product-treated EpiOral™ tissues was determined (ET50). Longer ET50 values indicate reduced irritation potential.

Result: 

Product

ET50 (hours)

REMBRANDT® GENTLE WHITE

> 24

REMBRANDT® INTENSE STAIN®

12.8

Crest® 3D White

5.1

Method Control (1% Triton X)

0.9

Conclusion: The data showed that the ET50 values for both REMBRANDT® dentifrices were longer compared to Crest® 3D White dentifrice, thus indicating their reduced irritation potential as assessed by exposure to the in-vitro model and testing platform used in our study.   Both surfactant-containing dentifrices (REMBRANDT® INTENSE STAIN® and Crest® 3D White) show increased irritation potential compared to the surfactant-free dentifrice (REMBRANDT® GENTLE WHITE), however the irritation potential is reduced for the dentifrice containing cocamidopropyl betaine as a surfactant instead of sodium lauryl sulfate, which is a known irritant.  These results showed that the in vitro testing method used is a reliable pre-screening tool for the assessment of oral irritation potential of dentifrices.

Division: AADR/CADR Annual Meeting
Meeting: 2014 AADR/CADR Annual Meeting (Charlotte, North Carolina)
Location: Charlotte, North Carolina
Year: 2014
Final Presentation ID: 568
Abstract Category|Abstract Category(s): Oral Health Research
Authors
  • Martinez, Marcee  ( Johnson & Johnson Consumer Companies, Inc, Morris Plains, NJ, USA )
  • Costin, Gertrude-emilia  ( Institute for In Vitro Sciences, Inc, Gaithersburg, MD, USA )
  • Mordas, Carolyn J.  ( Johnson & Johnson Consumer Companies, Inc, Skillman, NJ, USA )
  • SESSION INFORMATION
    Poster Session
    Safety and Efficacy Methods for Evaluation of Oral Care Products
    03/20/2014